CF
HCAT icon

Corebridge Financial’s Health Catalyst HCAT Stock Holding History

Corebridge Financial’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-29,317
Closed -$133K – 1185
2025
Q1 		$133K Sell
29,317
-436
-1% -$2.31K ﹤0.01% 2289
2024
Q4 		$210K Sell
29,753
-1,485
-5% -$11.8K ﹤0.01% 2153
2024
Q3 		$254K Sell
31,238
-192
-0.6% -$1.39K ﹤0.01% 2085
2024
Q2 		$201K Buy
+31,430
New +$202K ﹤0.01% 2191

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Corebridge Financial's HCAT Position: Q2 2025 in Review

Corebridge Financial sold out of Health Catalyst (HCAT) in Q2 2025, closing a stake of 29,317 shares — an estimated $133K sold.

Corebridge Financial first reported a position in HCAT in Q2 2024 and held it in 4 quarters. The position peaked at $254K in Q3 2024. 145 funds tracked by Wall St. Rank hold HCAT as of Q2 2025.

  • Corebridge Financial reported no remaining Health Catalyst position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 29,317 Health Catalyst shares in Q2 2025, an estimated $133K.
  • Corebridge Financial first reported a position in Health Catalyst in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Health Catalyst position peaked at $254K in Q3 2024.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.